Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Guignabert

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 14, 2016
Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 CleavageRobert Szulcek, Chris M Happé, Nina Rol, et al.
American Journal of Respiratory Cell and Molecular Biology|March 28, 2024
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell DysfunctionHélène Le Ribeuz, Anaïs Saint-Martin Willer, Benoit Chevalier, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 10, 2024
NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivityGuillaume Cardouat, Matthieu Douard, Clément Bouchet, et al.
The European Respiratory Journal|May 19, 2018
Optimising experimental research in respiratory diseases: an ERS statementPhilippe Bonniaud, Aurélie Fabre, Nelly Frossard, et al.
Circulation|September 24, 2013
Right ventricular diastolic impairment in patients with pulmonary arterial hypertensionSilvia Rain, M Louis Handoko, Pia Trip, et al.
Cardiovascular Research|July 23, 2018
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionNina Rol, Michiel A de Raaf, Xiaoqing Q Sun, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 18, 2022
Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohortJessie van Wezenbeek, Joanne A Groeneveldt, Aida Llucià-Valldeperas, et al.
Nature Genetics|March 19, 2013
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertensionMarine Germain, Mélanie Eyries, David Montani, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
American Journal of Respiratory and Critical Care Medicine|January 14, 2016
Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 CleavageRobert Szulcek, Chris M Happé, Nina Rol, et al.
American Journal of Respiratory Cell and Molecular Biology|March 28, 2024
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell DysfunctionHélène Le Ribeuz, Anaïs Saint-Martin Willer, Benoit Chevalier, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 10, 2024
NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivityGuillaume Cardouat, Matthieu Douard, Clément Bouchet, et al.
The European Respiratory Journal|May 19, 2018
Optimising experimental research in respiratory diseases: an ERS statementPhilippe Bonniaud, Aurélie Fabre, Nelly Frossard, et al.
Circulation|September 24, 2013
Right ventricular diastolic impairment in patients with pulmonary arterial hypertensionSilvia Rain, M Louis Handoko, Pia Trip, et al.
Cardiovascular Research|July 23, 2018
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionNina Rol, Michiel A de Raaf, Xiaoqing Q Sun, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 18, 2022
Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohortJessie van Wezenbeek, Joanne A Groeneveldt, Aida Llucià-Valldeperas, et al.
Nature Genetics|March 19, 2013
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertensionMarine Germain, Mélanie Eyries, David Montani, et al.
Pageof 16